There are 248 resources available
State of the art: Neoantigens, T-cell recognition and tumour rejection
Presenter: Yardena Samuels
Session: Tumour antigens and neoantigens
Resources:
Presentation
Immunoediting: Anti-tumour immunity and tumour evolution
Presenter: Rachel Rosenthal
Session: Tumour antigens and neoantigens
Resources:
Presentation
Translation: Clinical application of neoantigen-reactive T-cells
Presenter: Alena Gros
Session: Tumour antigens and neoantigens
Resources:
Presentation
Opportunities to reduce dosing frequency of checkpoint inhibitors
Presenter: Daniel Goldstein
Session: Reducing costs by decreasing either dose or frequency of dosing
Resources:
Presentation
Webcast
Dosing reductions of checkpoint inhibitors in lung cancer
Presenter: Berber Piet
Session: Reducing costs by decreasing either dose or frequency of dosing
Resources:
Presentation
Webcast
Biomarkers of response to checkpoint inhibition in glioblastoma
Presenter: Enrico Franceschi
Session: Brain tumours: Updates
Resources:
Presentation
Webcast
Immune checkpoint inhibition for glioblastoma: Update on the first three CheckMate trials
Presenter: Michael Weller
Session: Brain tumours: Updates
Resources:
Presentation
Webcast
Peptide based vaccination therapy for glioblastoma
Presenter: Denis Migliorini
Session: Brain tumours: Updates
Resources:
Presentation
Immune checkpoint inhibition for patients with brain metastasis: Patient selection and assessment of benefit
Presenter: Emilie Le Rhun
Session: Brain tumours: Updates
Resources:
Presentation
Combining PARP inhibition and immunotherapy in ovarian cancer
Presenter: Panagiotis Konstantinopoulos
Session: Breast and gynaecological cancers: Updates
Resources:
Presentation
Webcast